Insight Molecular Diagnostics Inc.
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 14 | Q1 15 | Q2 15 | Q3 15 | Q1 16 | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q1 18 | Q2 18 | Q3 18 | Q1 19 | Q2 19 | Q3 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q1 22 | Q2 22 | Q3 22 | Q1 23 | Q2 23 | Q3 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 132.9 | 183.7 | 121.5 | 70.9 | 30.6 | 28.0 | 51.9 | 42.5 | 35.0 | 20.4 | 17.6 | 32.9 | 48.3 | 22.2 | 20.7 | 22.6 | 24.0 | 56.4 | 58.4 | 129.8 | |
| – | – | – | – | 16.9 | 20.5 | 10.5 | 20.7 | 19.8 | 27.1 | 29.2 | 7.4 | 14.7 | 13.4 | 4.9 | 3.9 | 3.7 | 4.2 | 3.2 | 2.7 | 4.8 | 4.0 | 5.0 | 3.3 | 2.4 | 1.2 | 1.1 | 1.1 | 0.8 | 0.7 | 1.4 | 1.7 | 4.1 | – | 7.8 | 87.5 | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 129.3 | 159.8 | 111.0 | 62.3 | 26.7 | 16.1 | 33.2 | 31.3 | 19.3 | 10.0 | 14.1 | 25.9 | 45.7 | 18.3 | 13.0 | 17.2 | 20.1 | 54.0 | 44.9 | 120.2 | |
| – | – | – | – | -4.0% | -6.9% | -4.8% | -3.7% | -5.0% | -6.7% | -5.4% | -19.4% | -13.5% | -12.7% | -8.5% | -12.3% | -15.5% | -13.9% | -17.7% | -27.3% | -16.8% | -7.3% | -6.3% | -11.2% | -32.9% | -46.4% | -58.7% | -114.3% | -106.7% | -115.7% | -88.7% | -49.5% | -44.3% | -50.2% | -29.2% | -24.7% | -22.6% | -11.1% | -24.1% | -14.2% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -52.4% | -17.3% | -13.6% | -30.0% | -20.7% | -27.0% | -51.4% | 1.9% | 4.1% | 20.8% | 42.1% | 52.5% | 47.7% | 39.3% | 52.6% | 54.5% | 54.7% | 57.0% | 19.5% | 11.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -2,441.2% | -1,403.8% | -888.9% | -965.3% | -919.6% | -876.2% | -1,196.2% | -50.9% | -542.9% | -849.0% | -1,335.1% | -2,449.3% | -4,117.4% | -3,245.1% | -1,524.1% | -1,498.3% | -1,392.9% | -928.2% | -2,112.4% | -2,558.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -2,459.5% | -1,123.4% | -653.0% | -743.8% | -852.2% | -1,181.1% | -2,501.4% | -2,537.3% | -2,155.4% | -1,681.7% | -1,532.5% | -2,430.1% | -4,082.6% | -3,225.0% | -1,514.6% | -1,489.7% | -1,380.7% | -1,238.5% | -2,454.6% | -2,955.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -2,235.6% | -1,332.0% | -763.1% | -798.1% | -1,008.4% | -1,301.2% | -3,045.0% | -4,863.8% | -3,732.0% | -2,358.2% | -1,557.7% | -1,632.3% | -2,140.2% | -1,112.5% | -604.7% | -556.7% | -543.2% | -625.6% | -1,408.7% | -1,848.8% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| – | – | -185.8% | -75.0% | -117.8% | -208.1% | -82.7% | -113.3% | -147.6% | -251.9% | -230.1% | -212.7% | -277.4% | -241.4% | -39.6% | -49.9% | -59.5% | -60.6% | -69.3% | -83.3% | -89.4% | -24.5% | -26.8% | -34.7% | -67.6% | -48.7% | -54.3% | -65.6% | -47.5% | -56.2% | -123.6% | -125.5% | -346.4% | – | -569.6% | -5,775.7% | – | – | – | – | |
| -78.4% | – | -65.3% | -46.9% | -84.2% | -125.2% | -62.2% | -77.3% | -85.3% | -117.0% | -130.0% | -123.2% | -155.7% | -140.7% | -36.3% | -44.4% | -53.2% | -37.3% | -43.3% | -49.9% | -54.0% | -20.2% | -15.5% | -20.5% | -26.3% | -25.1% | -26.5% | -30.1% | -26.2% | -25.9% | -29.5% | -38.1% | -47.9% | -172.9% | -96.4% | -125.5% | -138.3% | -195.0% | -118.3% | -167.6% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| 5.6 | – | – | -8.9 | – | -3.8 | -12 | -9.8 | -11 | -7.5 | -10.0 | -11 | -8.9 | -9.1 | -38 | -35 | -18 | -15 | -15 | -7.8 | -4.3 | -56 | -44 | -40 | -18 | -43 | -31 | -11 | -17 | -13 | -4.8 | -8.2 | -2.1 | -7.3 | -30 | -23 | -17 | -9.8 | -26 | -16 | |
| -16.9% | – | 35.1% | 62.5% | 71.5% | 60.2% | 75.2% | 68.3% | 57.8% | 46.4% | 56.5% | 57.9% | 56.1% | 58.3% | 91.6% | 89.0% | 89.5% | 61.6% | 62.4% | 60.0% | 60.4% | 82.5% | 57.9% | 59.0% | 38.9% | 51.5% | 48.8% | 45.8% | 55.2% | 46.0% | 23.8% | 30.4% | 13.8% | -35.0% | 16.9% | 2.2% | -20.9% | -122.2% | -26.4% | -72.3% | |
| – | – | – | 0.1 | – | 0.0 | 0.0 | 0.0 | 0.1 | 0.2 | 0.1 | 0.2 | 0.2 | 0.2 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | – | 0.1 | 1.4 | – | – | – | – | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -4.58 | -4.72 | -4.90 | -5.28 | -6.40 | -7.31 | -7.89 | -7.78 | -8.94 | -9.66 | -11.97 | -12.12 | -9.81 | -9.03 | -6.48 | -6.44 | -6.71 | -7.23 | -8.34 | -8.58 | -8.89 | -6.36 | -6.13 | -7.55 | -8.35 | -7.59 | -7.04 | -4.17 | -2.83 | -2.56 | -2.53 | -2.21 | -2.45 | -3.49 | -2.27 | -1.98 | -1.90 | -1.65 | -1.39 | -1.34 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.36 | 0.57 | 0.94 | 1.01 | 0.98 | 0.64 | 0.28 | 0.16 | 0.13 | 0.15 | 0.17 | 0.09 | 0.06 | 0.11 | 0.15 | 0.13 | 0.14 | 0.13 | 0.06 | 0.05 | |
| -0.99 | -0.99 | 2.64 | 7.04 | 5.43 | 3.51 | 9.55 | 6.87 | 6.06 | 3.84 | 5.20 | 5.70 | 3.54 | 3.74 | 16.37 | 12.89 | 11.29 | 11.92 | 12.03 | 10.30 | 9.94 | 25.97 | 22.88 | 21.73 | 12.35 | 15.59 | 12.96 | 6.36 | 5.97 | 4.55 | 2.05 | 1.76 | 0.71 | -0.71 | 0.40 | 0.03 | -0.29 | -1.03 | -0.31 | -0.58 | |
| -1.08 | -1.07 | -1.81 | -2.64 | -3.72 | -5.00 | -4.83 | -5.31 | -6.04 | -6.99 | -8.23 | -8.13 | -7.00 | -6.33 | -6.84 | -6.17 | -6.51 | -6.94 | -6.72 | -7.66 | -8.08 | -7.54 | -7.16 | -8.10 | -9.88 | -8.36 | -8.56 | -8.00 | -4.91 | -3.59 | -2.57 | -1.49 | -1.29 | -1.20 | -0.90 | -0.74 | -0.75 | -0.83 | -0.80 | -0.84 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.